NCT03465774 2026-03-05
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
M.D. Anderson Cancer Center
Recruiting
Clinical Trials
28 trialsNCT06452394 2025-12-30
NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
Swiss Cancer Institute
Phase 2 Recruiting
NCT05521048 2025-12-08
Doxycycline in Cutaneous Schwannoma (NF2)
Massachusetts Eye and Ear Infirmary
Phase 1/2 Active not recruiting
NCT03435952 2025-10-14
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT02775695 2023-07-03
Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer
Medical College of Wisconsin
Phase 2 Completed
NCT02874430 2022-12-15
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Thomas Jefferson University
Phase 2 Unknown
NCT01874860 2022-12-01
Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
University of Louisville
Phase 2 Completed
NCT02583282 2022-10-06
A Study to Compare the Efficacy and Safety of Intrapleural Doxycycline Versus Iodopovidone for Performing Pleurodesis in Malignant Pleural Effusion
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase NA Completed
NCT04864717 2021-09-08
Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI
Lady Davis Institute
Phase 4 Unknown
NCT02207556 2021-07-09
DUAL
Medical College of Wisconsin
Phase 2 Completed
NCT02341209 2021-04-27
CTCL
Rochester General Hospital
Phase 2 Terminated
NCT03401372 2021-02-23
BCD With or Without Doxycycline in Mayo Stage II-III Light Chain Amyloidosis Patients
Peking Union Medical College Hospital
Phase NA Completed
NCT01411202 2020-09-25
OPUS
Ottawa Hospital Research Institute
Phase 2 Unknown
NCT01590082 2020-09-02
Doxycycline, Temozolomide and Ipilimumab in Melanoma
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT03448731 2020-04-08
DERMIA
Fundacion CRIS de Investigación para Vencer el Cáncer
Phase 2 Completed
NCT01317433 2020-03-25
SKINUX
Institut Cancerologie de l'Ouest
Phase NA Terminated
NCT01867294 2020-01-09
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Academic and Community Cancer Research United
Phase 2 Completed
NCT01847976 2019-09-06
OTT12-05
Ottawa Hospital Research Institute
Phase 2 Completed
NCT02623959 2019-08-07
Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT03454945 2018-08-23
Efficacy of Doxycycline in the Treatment of Early Stages of Mycosis Fungoides
Cairo University
Phase 3 Unknown
NCT01677286 2017-08-01
Safety and Effect of Doxycycline in Patients With Amyloidosis
Boston University
Phase 2 Completed
NCT02086591 2016-12-22
A Phase II Study of Doxycycline in Relapsed NHL
University of Rochester
Phase 2 Terminated
NCT01668498 2016-04-19
Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer
AIO-Studien-gGmbH
Phase 2 Completed
NCT00989742 2015-12-02
Doxycycline In Lymphangioleiomyomatosis (LAM)
University of Nottingham
Phase 4 Completed
NCT00830401 2015-06-04
The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases
UMC Utrecht
Phase 2 Terminated
NCT00803842 2015-02-26
Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash
Northwestern University
Phase NA Withdrawn
NCT01010295 2013-11-25
IELSG27
International Extranodal Lymphoma Study Group (IELSG)
Phase 2 Completed
NCT00783523 2013-08-09
Influence of MMP on Brain AVM Hemorrhage
University of California, San Francisco
Phase 1 Completed